Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 124,466 shares at $5.32 ($663K) on 2017-01-24, disclosed to the SEC on 2017-01-25.
Open-market purchase of $663k MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.27 | 19,251 | $101K | 15.3% |
| 2 | $5.27 | 19,251 | $101K | 15.3% |
| 3 | $5.32 | 27,682 | $147K | 22.2% |
| 4 | $5.32 | 27,682 | $147K | 22.2% |
| 5 | $5.42 | 30,600 | $166K | 25.0% |
| Total | $5.33 avg | 124,466 |
| $663K |
| 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |